ArticleBMC research notes2026
Molecular detection and low prevalence of Human Herpesvirus 6 (HHV-6) among male blood donors in Kassala, Sudan: a preliminary single-center study.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A dual-method assessment of West Nile and Chikungunya viruses in blood donations from Fars province, southwestern Iran.Parasite epidemiology and control · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveHuman herpesvirus 6 (HHV-6) is a latent beta-herpesvirus with potential transfusion-transmissible relevance, particularly in immunocompromised recipients. Data on HHV-6 viremia among Sudanese blood donors are extremely limited. This study aimed to determine the molecular prevalence of HHV-6 DNA among blood donors in Kassala, Sudan. A descriptive cross-sectional study was conducted at Kassala Teaching Hospital. Only male donors were included due to extremely low female donation rates in this setting. Whole-blood samples (n = 180) were screened for HHV-6 DNA using real-time PCR, followed by multiplex PCR for genotyping attempts. Due to the small number of positive cases, comparisons were considered exploratory and descriptive.
resultsHHV-6 DNA was detected in 2.78% (5/180) of donors. No significant associations were found between HHV-6 positivity and age group, region, or ABO/Rh blood groups. Hematological parameters showed no significant differences between HHV-6-positive and negative donors. Genotyping was unsuccessful for all positive samples, likely due to the high cycle threshold (Ct) values (38.7-39.9), indicating low viral DNA levels. HHV-6 viremia was infrequent among blood donors in Kassala. Given the very small number of positive cases (n = 5), failed genotyping, and lack of serological confirmation, these findings are exploratory and preliminary. Larger multicenter studies with more sensitive methods are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.